| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Quest Diagnostics has extended its QuestDirect COVID-19 Testing Program to small businesses. The program, which was designed to help small businesses foster safer environments for their employees and customers using insights from easy, fast and convenient COVID-19 molecular diagnostic and/or antibody testing services, is now available for wider use.
As the COVID-19 pandemic continues, workers at Quest Diagnostics are sharing what it's been like working on the front lines. Quest is a leader in diagnostic testing throughout the nation and has played a critical role during the pandemic.
Preventive tests fell sharply in the early weeks of the pandemic. Although they've started to rebound, many patients remain undiagnosed or face waits for office visits. To combat this, several insurers sent at-home colon cancer screenings kits to patients who were due for their exam. Last month, Quest Diagnostics rolled out a similar type of at-home screening. The company made its first bet in consumer-directed testing long before the start of the pandemic, when it launched an at-home STD test in 2019.
Prescription and illicit drug testing rates declined during the COVID-19 pandemic in 2020, according to a study published in the journal Population Health Management. Harvey W Kaufman, MD, MBA, FCAP, senior medical director, information ventures and office of chief medical officer at Quest Diagnostics conducted the study along with colleagues.
Quest Diagnostics had been preparing for 2020 for two years. As one of the top medical-testing providers in the nation, it first launched its consumer-initiated testing program, QuestDirect, at the end of 2018. Through it, consumers can visit the company's website and order at-home testing kits for 49 different conditions.